ZWJ Investment Counsel Inc. Sells 96 Shares of Stryker Corporation $SYK

ZWJ Investment Counsel Inc. lowered its stake in shares of Stryker Corporation (NYSE:SYK) by 10.3% during the 2nd quarter, Holdings Channel.com reports. The fund owned 834 shares of the medical technology company’s stock after selling 96 shares during the quarter. ZWJ Investment Counsel Inc.’s holdings in Stryker were worth $330,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Goodman Advisory Group LLC bought a new position in shares of Stryker in the 1st quarter worth approximately $32,000. City Holding Co. lifted its stake in shares of Stryker by 528.6% in the 1st quarter. City Holding Co. now owns 88 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 74 shares during the period. Ridgewood Investments LLC lifted its stake in shares of Stryker by 48.4% in the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock worth $36,000 after purchasing an additional 30 shares during the period. Ransom Advisory Ltd bought a new position in shares of Stryker in the 1st quarter worth approximately $37,000. Finally, Smallwood Wealth Investment Management LLC bought a new position in shares of Stryker in the 1st quarter worth approximately $40,000. Institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling

In related news, insider Viju Menon sold 500 shares of the firm’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider directly owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the transaction, the director directly owned 3,222,108 shares of the company’s stock, valued at approximately $1,212,962,556.60. This trade represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.90% of the company’s stock.

Stryker Trading Up 1.1%

Shares of SYK opened at $370.59 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The company has a 50 day simple moving average of $382.81 and a two-hundred day simple moving average of $378.93. The firm has a market cap of $141.68 billion, a P/E ratio of 49.08, a price-to-earnings-growth ratio of 2.67 and a beta of 0.94.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.07 by $0.06. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. During the same period last year, the firm posted $2.81 EPS. The company’s revenue was up 11.1% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, equities analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker’s dividend payout ratio (DPR) is 44.50%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on SYK. Evercore ISI increased their price objective on shares of Stryker from $390.00 to $415.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 8th. BTIG Research restated a “buy” rating on shares of Stryker in a research note on Monday, July 14th. Redburn Partners set a $420.00 target price on shares of Stryker in a research note on Thursday, September 18th. Wells Fargo & Company raised their target price on shares of Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Finally, Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research note on Friday, September 26th. Fifteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and an average price target of $430.33.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.